End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 CAD | 0.00% | 0.00% | +5.26% |
14/05 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
14/05 | Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 140 times its estimated earnings per share for the ongoing year.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.26% | 16Cr | - | ||
+7.31% | 22TCr | B | ||
+12.99% | 19TCr | B- | ||
+19.71% | 14TCr | B- | ||
+30.60% | 11TCr | A- | ||
+2.47% | 6.43TCr | A- | ||
+15.23% | 5.29TCr | B+ | ||
+2.06% | 4.95TCr | B+ | ||
-5.49% | 3.83TCr | A | ||
-0.22% | 3.52TCr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HTL Stock
- Ratings Hamilton Thorne Ltd.